Literature DB >> 3119118

Angiotensin converting enzyme inhibitors in the elderly.

J L Reid1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3119118      PMCID： PMC1247997          DOI： 10.1136/bmj.295.6604.943

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  13 in total

Review 1.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

2.  Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  A A Ajayi; N Hockings; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 3.  Angiotensin-converting enzyme inhibitors: past, present, and bright future.

Authors:  C R Edwards; P L Padfield
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

4.  [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].

Authors:  F Forette; R Handfield-Jones; M Henry-Amar; M Fouchard; P Bouchacourt; M P Hervy; J F Henry; E Mesguisch-Billaud; J M Alexandre
Journal:  Presse Med       Date:  1985-12-19       Impact factor: 1.228

5.  Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  N Hockings; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

6.  Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

Authors:  J Cleland; P Semple; P Hodsman; S Ball; I Ford; H Dargie
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

7.  Captopril in the treatment of the elderly hypertensive patient.

Authors:  A C Jenkins; J R Knill; G R Dreslinski
Journal:  Arch Intern Med       Date:  1985-11

8.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.

Authors:  A J Man in 't Veld; I M Schicht; F H Derkx; J H de Bruyn; M A Schalekamp
Journal:  Br Med J       Date:  1980-02-02

9.  Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.

Authors:  W D Cooper; D Sheldon; D Brown; G R Kimber; V L Isitt; W J Currie
Journal:  J R Coll Gen Pract       Date:  1987-08

10.  Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Authors:  G P Hodsman; C G Isles; G D Murray; T P Usherwood; D J Webb; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12
View more
  8 in total

1.  Unexpected first dose hypotensive reaction to enalapril.

Authors:  P J Mullen
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 2.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 3.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

4.  Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the rat.

Authors:  R D Carr; A E Cooper; R Hutchinson; J Mann; S E O'Connor; D H Robinson; E Wells
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

5.  Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly.

Authors:  G Kaiser; R Ackermann; W Dieterle; C J Durnin; J McEwen; K Ghose; A Richens; I B Holmes
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br Heart J       Date:  1991-09

Review 7.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

8.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.